Efficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra.

Keidel, Sarah M; Hoyles, Rachel K; Wilkinson, Nick M R

Keidel, Sarah M; Hoyles, Rachel K; Wilkinson, Nick M R.

Affiliation

Keidel SM; Paediatric Rheumatology, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7HE, UK. nick.wilkinson@ouh.nhs.uk.

Rheumatology (Oxford) ; 53(3): 573-4, 2014 Mar.

Article in En | MEDLINE | ID: mdl-23970544

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Interleukin 1 Receptor Antagonist Protein/therapeutic use; Lung Diseases, Interstitial/drug therapy; Urticaria/drug therapy; Vasculitis/drug therapy; Adolescent; Comorbidity; Female; Humans; Interleukin-6/antagonists & inhibitors; Lung Diseases, Interstitial/epidemiology; Treatment Outcome; Urticaria/epidemiology; Vasculitis/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Vasculitis / Lung Diseases, Interstitial / Interleukin 1 Receptor Antagonist Protein / Antibodies, Monoclonal, Humanized Limits: Adolescent / Female / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google